Det firma, der fremstiller Gliolan, vil inden markedsføringen i alle EU' s medlemsstater afholde kurser for hjernekirurger, hvor de vil blive sat ind i risikofri og effektiv anvendelse af lægemidlet under operationer.
Before the medicine is launched, the company that makes Gliolan will set up training courses in all Member States for brain surgeons to inform them about how to use the medicine safely and effectively during surgery.